Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bielekova

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|November 3, 2001
Antigen-specific immunomodulation via altered peptide ligandsB Bielekova, R Martin
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseasesB Bielekova, A Lincoln, H McFarland, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
Lessons from studies of antigen-specific T cell responses in Multiple SclerosisR Martin, B Bielekova, B Gran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosisA Holz, B Bielekova, R Martin, et al.
Journal of Neuroimmunology|November 7, 2000
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosisP A Muraro, T Leist, B Bielekova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidityP A Muraro, M Pette, B Bielekova, et al.
Journal of Neuroimmunology|March 1, 2000
Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7B Bielekova, P A Muraro, L Golestaneh, et al.
Neurology|December 13, 2000
Mechanisms of immunomodulation by glatiramer acetateB Gran, L R Tranquill, M Chen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 31, 2015
CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MSJ Elkins, J Sheridan, L Amaravadi, et al.
Neurology|November 15, 2011
Intrathecal effects of daclizumab treatment of multiple sclerosisB Bielekova, N Richert, M L Herman, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Molecular Medicine (Berlin, Germany)|November 3, 2001
Antigen-specific immunomodulation via altered peptide ligandsB Bielekova, R Martin
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseasesB Bielekova, A Lincoln, H McFarland, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
Lessons from studies of antigen-specific T cell responses in Multiple SclerosisR Martin, B Bielekova, B Gran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosisA Holz, B Bielekova, R Martin, et al.
Journal of Neuroimmunology|November 7, 2000
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosisP A Muraro, T Leist, B Bielekova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidityP A Muraro, M Pette, B Bielekova, et al.
Journal of Neuroimmunology|March 1, 2000
Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7B Bielekova, P A Muraro, L Golestaneh, et al.
Neurology|December 13, 2000
Mechanisms of immunomodulation by glatiramer acetateB Gran, L R Tranquill, M Chen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 31, 2015
CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MSJ Elkins, J Sheridan, L Amaravadi, et al.
Neurology|November 15, 2011
Intrathecal effects of daclizumab treatment of multiple sclerosisB Bielekova, N Richert, M L Herman, et al.
Pageof 2